| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |